NELL2, a novel osteoinductive factor, regulates osteoblast differentiation and bone homeostasis through fibronectin 1/integrin-mediated FAK/AKT signaling

Abstract

Neural EGFL-like 2 (NELL2) is a secreted protein known for its regulatory functions in the nervous and reproductive systems, yet its role in bone biology remains unexplored. In this study, we observed that NELL2 was diminished in the bone of aged and ovariectomized (OVX) mice, as well as in the serum of osteopenia and osteoporosis patients. In vitro loss-of-function and gain-of-function studies revealed that NELL2 facilitated osteoblast differentiation and impeded adipocyte differentiation from stromal progenitor cells. In vivo studies further demonstrated that the deletion of NELL2 in preosteoblasts resulted in decreased cancellous bone mass in mice. Mechanistically, NELL2 interacted with the FNI-type domain located at the C-terminus of Fibronectin 1 (Fn1). Moreover, we found that NELL2 activated the focal adhesion kinase (FAK)/AKT signaling pathway through Fn1/integrin β1 (ITGB1), leading to the promotion of osteogenesis and the inhibition of adipogenesis. Notably, administration of NELL2-AAV was found to ameliorate bone loss in OVX mice. These findings underscore the significant role of NELL2 in osteoblast differentiation and bone homeostasis, suggesting its potential as a therapeutic target for managing osteoporosis.

Keywords

Medical and Health Sciences / Clinical Sciences

References

[1] Wang, L. H. et al. Prevalence of osteoporosis and fracture in China the China Osteoporosis Prevalence Study. JAMA Netw. Open4 (2021).

[2] BolampertiS, VillaI, RubinacciA. Bone remodeling: an operational process ensuring survival and bone mechanical competence. Bone Res., 2022, 10: 48.

[3] XuH, et al. . Targeting strategies for bone diseases: signaling pathways and clinical studies. Signal Transduct. Target Ther., 2023, 8: 202.

[4] FengH, et al. . Skeletal stem cells: origins, definitions, and functions in bone development and disease. Life Med., 2022, 1: 276-293.

[5] YuanG, LinX, LiuY, GreenblattMB, XuR. Skeletal stem cells in bone development, homeostasis, and disease. Protein Cell, 2024, 15: 559-574.

[6] MelisS, TrompetD, ChaginAS, MaesC. Skeletal stem and progenitor cells in bone physiology, ageing and disease. Nat. Rev. Endocrinol., 2025, 21: 135-153.

[7] ZhongL, et al. . Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment. Elife, 2020, 9: e54695.

[8] BaccinC, et al. . Combined single-cell and spatial transcriptomics reveal the molecular, cellular and spatial bone marrow niche organization. Nat. Cell Biol., 2020, 22: 38-48.

[9] Zhang, Y. et al. Neuronal induction of bone-fat imbalance through osteocyte neuropeptide Y. Adv. Sci.8 (2021).

[10] PaccouJ, PenelG, ChauveauC, CortetB, HardouinP. Marrow adiposity and bone: Review of clinical implications. Bone, 2019, 118: 8-15.

[11] HojoH, et al. . Emerging RUNX2-Mediated gene regulatory mechanisms consisting of multi-layered regulatory networks in skeletal development. Int. J. Mol. Sci., 2023, 24: 2979.

[12] LiuQ, et al. . Recent advances of osterix transcription factor in osteoblast differentiation and bone formation. Front. Cell Dev. Biol., 2020, 8. 601224

[13] VlashiR, ZhangXE, WuMR, ChenGQ. Wnt signaling: Essential roles in osteoblast differentiation, bone metabolism and therapeutic implications for bone and skeletal disorders. Genes Dis., 2023, 10: 1291-1317.

[14] ChenM, et al. . Metastasis suppressor 1 controls osteoblast differentiation and bone homeostasis through regulating Src-Wnt/beta-catenin signaling. Cell Mol. Life Sci., 2022, 79: 107.

[15] MbalavieleG, et al. . Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J. Cell Biochem., 2005, 94: 403-418.

[16] EvseevaMN, BalashovaMS, KulebyakinKY, RubtsovYP. Adipocyte biology from the perspective of in vivo research: review of key transcription factors. Int. J. Mol. Sci., 2022, 23: 322.

[17] WatanabeTK, et al. . Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats. Genomics, 1996, 38: 273-276.

[18] NelsonBR, ClaesK, ToddV, ChaverraM, LefcortF. NELL2 promotes motor and sensory neuron differentiation and stimulates mitogenesis in DRG in vivo. Dev. Biol., 2004, 270: 322-335.

[19] MatsuyamaS, et al. . Spatial learning of mice lacking a neuron-specific epidermal growth factor family protein, NELL2. J. Pharm. Sci., 2005, 98: 239-243.

[20] JeongJK, et al. . A role of central NELL2 in the regulation of feeding behavior in rats. Mol. Cells, 2017, 40: 186-194.

[21] KimHR, et al. . NELL2 function in axon development of hippocampal neurons. Mol. Cells, 2020, 43: 581-589

[22] PakJS, et al. . NELL2-Robo3 complex structure reveals mechanisms of receptor activation for axon guidance. Nat. Commun., 2020, 11. 1489

[23] KiyozumiD, et al. . NELL2-mediated lumicrine signaling through OVCH2 is required for male fertility. Science, 2020, 368: 1132-1135.

[24] JamesAW, et al. . NELL-1 in the treatment of osteoporotic bone loss. Nat. Commun., 2015, 6. 7362

[25] LiC, et al. . Nell-1 Is a key functional modulator in osteochondrogenesis and beyond. J. Dent. Res., 2019, 98: 1458-1468.

[26] QiH, et al. . Inactivation of Nell-1 in chondrocytes significantly impedes appendicular skeletogenesis. J. Bone Miner. Res., 2019, 34: 533-546.

[27] WangL, et al. . NELL1 Augments osteogenesis and inhibits inflammation of human periodontal ligament stem cells induced by BMP9. J. Periodontol., 2021, 93: 977-987.

[28] GahmbergCG, et al. . Regulation of cell adhesion: a collaborative effort of integrins, their ligands, cytoplasmic actors, and phosphorylation. Q Rev. Biophys., 2019, 52. e10

[29] ZhaoY, SunQ, HuoB. Focal adhesion regulates osteogenic differentiation of mesenchymal stem cells and osteoblasts. Biomater. Transl., 2021, 2: 312-322

[30] BakerN, SohnJ, TuanRS. Promotion of human mesenchymal stem cell osteogenesis by PI3-kinase/Akt signaling, and the influence of caveolin-1/cholesterol homeostasis. Stem Cell Res. Ther., 2015, 6: 238.

[31] TruongT, ZhangX, PathmanathanD, SooC, TingK. Craniosynostosis-associated gene nell-1 is regulated by runx2. J. Bone Miner. Res., 2007, 22: 7-18.

[32] ZhangX, et al. . Overexpression of Nell-1, a craniosynostosis-associated gene, induces apoptosis in osteoblasts during craniofacial development. J. Bone Miner. Res., 2003, 18: 2126-2134.

[33] ZhangX, ZaraJ, SiuRK, TingK, SooC. The role of NELL-1, a growth factor associated with craniosynostosis, in promoting bone regeneration. J. Dent. Res., 2010, 89: 865-878.

[34] JamesAW, et al. . NELL-1 induces Sca-1+ mesenchymal progenitor cell expansion in models of bone maintenance and repair. JCI Insight, 2017, 2: e92573.

[35] ZhangX, et al. . Craniosynostosis in transgenic mice overexpressing Nell-1. J. Clin. Invest., 2002, 110: 861-870.

[36] DesaiJ, et al. . Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects. Hum. Mol. Genet., 2006, 15: 1329-1341.

[37] ChenX, et al. . Cumulative inactivation of Nell-1 in Wnt1 expressing cell lineages results in craniofacial skeletal hypoplasia and postnatal hydrocephalus. Cell Death Differ., 2020, 27: 1415-1430.

[38] ChenJ, WuJ, LuoY, HuangN. NELL2 as a potential marker of outcome in the cerebrospinal fluid of patients with tuberculous meningitis: preliminary results from a single-center observational study. Eur. J. Med. Res., 2022, 27. 281

[39] BuccitelliC, SelbachM. mRNAs, proteins and the emerging principles of gene expression control. Nat. Rev. Genet., 2020, 21: 630-644.

[40] LiuJ, et al. . NELL2 modulates cell proliferation and apoptosis via ERK pathway in the development of benign prostatic hyperplasia. Clin. Sci., 2021, 135: 1591-1608.

[41] JaworskiA, et al. . Operational redundancy in axon guidance through the multifunctional receptor Robo3 and its ligand NELL2. Science, 2015, 350: 961-965.

[42] RyuBJ, KimHR, JeongJK, LeeBJ. Regulation of the female rat estrous cycle by a neural cell-specific epidermal growth factor-like repeat domain containing protein, NELL2. Mol. Cells, 2011, 32: 203-207.

[43] JiangL, SunJ, HuangD. Role of Slit/Robo signaling pathway in bone metabolism. Int. J. Biol. Sci., 2022, 18: 1303-1312.

[44] CampE, AndersonPJ, ZannettinoACW, GronthosS. Tyrosine kinase receptor c-ros-oncogene 1 mediates TWIST-1 regulation of human mesenchymal stem cell lineage commitment. Bone, 2017, 94: 98-107.

[45] HynesRO. The extracellular matrix: not just pretty fibrils. Science, 2009, 326: 1216-1219.

[46] WijelathES, et al. . Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ. Res., 2006, 99: 853-860.

[47] RahmanS, et al. . Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells. BMC Cell Biol., 2005, 6. 8

[48] ten DijkeP, ArthurHM. Extracellular control of TGFbeta signalling in vascular development and disease. Nat. Rev. Mol. Cell Biol., 2007, 8: 857-869.

[49] FontanaL, et al. . Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1. FASEB J., 2005, 19: 1798-1808.

[50] WangY, ZhaoL, SmasC, SulHS. Pref-1 interacts with fibronectin to inhibit adipocyte differentiation. Mol. Cell Biol., 2010, 30: 3480-3492.

[51] PattenJ, WangK. Fibronectin in development and wound healing. Adv. Drug Deliv. Rev., 2021, 170: 353-368.

[52] ZollingerAJ, SmithML. Fibronectin, the extracellular glue. Matrix Biol., 2017, 60-61: 27-37.

[53] ToWS, MidwoodKS. Plasma and cellular fibronectin: distinct and independent functions during tissue repair. Fibrogenes. Tissue Repair, 2011, 4: 21.

[54] BentmannA, et al. . Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function. J. Bone Miner. Res., 2010, 25: 706-715.

[55] SensC, et al. . Fibronectins containing extradomain A or B enhance osteoblast differentiation via distinct integrins. J. Biol. Chem., 2017, 292: 7745-7760.

[56] CampbellID, HumphriesMJ. Integrin structure, activation, and interactions. Cold Spring Harb. Perspect. Biol., 2011, 3: a004994.

[57] DochevaD, PopovC, AlbertonP, AszodiA. Integrin signaling in skeletal development and function. Birth Defects Res. C., 2014, 102: 13-36.

[58] KimSH, TurnbullJ, GuimondS. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J. Endocrinol., 2011, 209: 139-151.

[59] SunC, et al. . FAK promotes osteoblast progenitor cell proliferation and differentiation by enhancing WNT signaling. J. Bone Miner. Res., 2016, 31: 2227-2238.

[60] QiS, et al. . FAK promotes early osteoprogenitor cell proliferation by enhancing mTORC1 signaling. J. Bone Miner. Res., 2020, 35: 1798-1811.

[61] HasebeA, et al. . The C-terminal region of NELL1 mediates osteoblastic cell adhesion through integrin alpha3beta1. FEBS Lett., 2012, 586: 2500-2506.

[62] YangYS, et al. . Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis. Nat. Commun., 2019, 10. 2958

Funding

National Natural Science Foundation of China (National Science Foundation of China)(82272444)

China Postdoctoral Science Foundation(2022M722382)

RIGHTS & PERMISSIONS

The Author(s)